• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10618
Device Problems Defective Device (2588); Device Contamination with Chemical or Other Material (2944); Material Deformation (2976); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2021
Event Type  Injury  
Event Description
It was reported that stent under expansion and damage occurred.The target lesion was located in the left anterior descending artery.After pre-dilatation was performed, a 3.5x16mm synergy drug-eluting stent (des) was advanced for treatment.However, during deployment, it was noticed that there was a black colored structure present in the middle of the stent delivery system.It was felt that there was an under expansion in the mid portion of the deployed stent, so that segment was post-dilated.It was then noted there was stent malformation and elongation with the length observed as 20mm instead of 16mm as per the labeling.A long des of another company was deployed to complete the procedure.No patient complications were reported.
 
Manufacturer Narrative
Correction: e1: initial reporter first name corrected from h to vs.
 
Event Description
It was reported that stent damage and stent under expansion occurred.The target lesion was located in the left anterior descending artery.After a 6f guiding catheter was inserted and pre-dilatation was performed, a 3.5x16mm synergy drug-eluting stent (des) was advanced for treatment.However, during deployment, it was noticed that there was a black structure present in the middle of the stent delivery system.As he felt that there was an under expansion in the mid portion of the deployed stent, he post-dilated the segment and noticed that there was a malformation and stent elongation occurred and the length was observed to be 20mm instead of 16mm of its labeled length.A long des of another company was deployed to complete the procedure.No patient complications were reported.
 
Manufacturer Narrative
Updated the following fields: d4.Lot number, d4.Expiration date, d4.Unique identifier (udi) #, and h4: device manufacture date.
 
Event Description
It was reported that stent damage and stent under expansion occurred.The target lesion was located in the left anterior descending artery.After a 6f guiding catheter was inserted and pre-dilatation was performed, a 3.5x16mm synergy drug-eluting stent (des) was advanced for treatment.However, during deployment, it was noticed that there was a black structure present in the middle of the stent delivery system.As he felt that there was an under expansion in the mid portion of the deployed stent, he post-dilated the segment and noticed that there was a malformation and stent elongation occurred and the length was observed to be 20mm instead of 16mm of its labeled length.A long des of another company was deployed to complete the procedure.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key12752831
MDR Text Key280175366
Report Number2134265-2021-13551
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/25/2023
Device Model Number10618
Device Catalogue Number10618
Device Lot Number0027434088
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-